2021 annual financial data
Beam Therapeutics 2021 Operating margin
Beam Therapeutics 2021 operating margin with verified reported values.
Direct answer
Operating margin was -757.01%.
Operating income was -392,465,000 USD and net income was -370,638,000 USD.
Operating cash flow was -66,268,000 USD.
Verified data
- Revenue
- 51,844,000 USD
- Operating income
- -392,465,000 USD
- Net income
- -370,638,000 USD
- Operating cash flow
- -66,268,000 USD